NEW DELHI, Sept 22 (Reuters) - All Indian children aged 12 or older will develop into eligible for COVID-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the rely advised Reuters.
the area's first DNA-primarily based COVID-19 vaccine, ZyCoV-D gained emergency authorisation from Indian regulators remaining month. From October, the company, better called Zydus Cadila, will produce 10 million doses a month.
The fitness ministry didn't instantly respond to a request for comment. The sources sought anonymity because they were now not authorised to confer with media.
The vaccine is the only 1 authorised for little ones in India, which has given a total of 825.9 million doses to adults amongst its population of just about 1.four billion. (Reporting via Neha Arora and Krishna N. Das; editing via Clarence Fernandez)
0 Comments